Abstract: Provided are antibodies directed against a novel epitope on the human C3c (complement factor 3 c) and the use and manufacture thereof. Moreover, there is provided a novel immunogen for use in the preparation of the antibodies. The antibodies are in the first place of the monoclonal type.
Type:
Application
Filed:
May 17, 2011
Publication date:
July 11, 2013
Applicant:
Sydansk Universitet
Inventors:
Mikkel Ole Skjoedt, Lars Vitved, Yaseelan Palarasah